R programming homework ghostwriting | ghostwriting R programming classification homework | ghostwriting R homework | ghostwriting R language homework

The first part: the introduction of the A and B schemes in the table: During the 0-24th week of the study, the subject scheme is a dynamic scheme.

If HBeAg>60 S/CO at the time of enrollment, drug A, namely Tiaoganyipi granules + entecavir placebo (plan A), will be administered, and then every 4 weeks will be checked to determine the subsequent treatment plan (see Part II)                                                                                                                                         

If HBeAg<60 S/CO at the time of enrollment, drug B, namely Tiaoganjianpijiedu granules + entecavir (scheme B), was administered until the end of the 24th week.                                                                                                                                       

                                                                                                                                         

Part II: Dynamic switching of drug regimens                                                                                                                                         

For the patients who applied program A after enrollment, in the first 24 weeks, liver function tests containing ALT and five tests of hepatitis B containing HBeAg were performed every 4 weeks, and drug switching was performed according to the indicators.                                                                                                                                     

The initiation mechanism of drug switching is as follows: in the first 24 weeks, for the initial use of drug regimen A, if the following two conditions occur during the medication process (1. ALT≥8×ULN and HBeAg<200 S/CO, or 2.HBeAg<60 S/CO) was switched to Tiaoganjianpijiedu granules + entecavir for 24 weeks. (A→B)                                                                                                                                            

                                                                                                                                         

Part 3: Drug Codes (only for the first 24 weeks of the drug regimen, starting from the 25th week, the regimen will be unified, see Part 4)                                                                                                                                   

AB scheme: in the first 24 weeks, the initial use of the A drug scheme has drug conversion, from A to B, recorded as AB scheme                                                                                                                                        

AA regimen: In the first 24 weeks, those who initially used drug regimen A did not meet the conditions for drug switching, and regimen A was always used.                                                                                                                                      

BB regimen: In the first 24 weeks, there is no drug switch in the first 24 weeks for those who initially use the B drug regimen, and the B regimen is always used.                                                                                                                                    

                                                                                                                                         

Part 4: All patients, regardless of previous regimen, were switched to regimen B starting at week 25 until the end of the 108-week study.                                                                                                                                     

Part 5: Regarding the control group: The rules of Parts 1 to 4 above are also applicable to the control group. The control group also has two sets of programs, A and B. The difference from the experimental group is that both drugs in the control group, A and B, are both traditional Chinese medicine simulants + western medicine entecavir.

 

About efficacy indicators

HBeAg was the main efficacy indicator, and the subject evaluated the HBeAg negative (<1 s/co) rate of the two groups at 108 weeks.

HBV DNA is a secondary efficacy indicator, which is converted into Log10IU/ML in this table, and the minimum detection limit is 500IU/ml (<500 IU/Ml is negative conversion, which is uniformly counted as 2.7log10IU/ml in this table)

http://www.daixie0.com/contents/18/1229.html

 

The core members of the team mainly include Silicon Valley engineers, BAT front-line engineers, top 5 master and doctoral students in China, and are proficient in German and English! Our main business scope is to do programming assignments, course design and so on.

Our field of direction: window programming, numerical algorithm, AI, artificial intelligence, financial statistics, econometric analysis, big data, network programming, WEB programming, communication programming, game programming, multimedia linux, plug-in programming program, API, image processing, embedded/MCU database programming, console process and thread, network security, assembly language hardware Programming software design engineering standards and regulations. The ghostwriting programming languages ​​or tools include but are not limited to the following scopes:
C/C++/C# ghostwriting
Java ghostwriting
IT ghostwriting
Python ghostwriting
tutoring programming assignments
Matlab
ghostwriting Haskell ghostwriting
Processing ghostwriting
Linux environment Building
Rust ghostwriting
Data Structure Assginment Data Structure Ghostwriting
MIPS Ghostwriting
Machine Learning Homework Ghostwriting
Oracle/SQL/PostgreSQL/Pig Database Ghostwriting / Assistant Doing / Tutoring
Web Development, Website Development, Website HomeworkASP.NET
Website Development
Finance Insurace Statistics Statistics, Regression, Iterate
Prolog to write
Computer Computational method

Because professional, so trustworthy. If necessary, please add QQ: 99515681 or email: [email protected] WeChat: codinghelp

Guess you like

Origin http://43.154.161.224:23101/article/api/json?id=324539179&siteId=291194637